Clinical Trial Update: Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial [Phase 1]

View source ↗

Summary

Phase 1, placebo-controlled trial evaluating safety, tolerability, immunogenicity and efficacy of a novel specific immunotherapy method for cat allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cat Allergy

Snippet

Sponsor: University of Zurich | Conditions: Allergy to Cat Dander | Phase 1 | Status: COMPLETED